As of November 2024, Noxopharm has a market cap of $19.77M. This makes Noxopharm the world's 30134th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $11.86M | -15.49% |
2023 | $14.04M | -51.03% |
2022 | $28.67M | -62.82% |
2021 | $77.11M | -20.41% |
2020 | $96.88M | 75.00% |
2019 | $55.36M | -33.33% |
2018 | $83.04M | -62.83% |
2017 | $223.41M | 169.05% |
2016 | $83.04M | - |